Acorda Therapeutics, Inc. (ACOR)
NASDAQ: ACOR · IEX Real-Time Price · USD
12.50
+0.40 (3.31%)
Mar 28, 2024, 2:12 PM EDT - Market open

Acorda Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 2003
Cash & Equivalents
44.6865.22102.9105.19294.35307.48158.62159.24183.3848.31
Upgrade
Short-Term Investments
00063.75151.9900200.1125.45225.89
Upgrade
Cash & Cash Equivalents
44.6865.22102.9168.95446.34307.48158.62359.34308.82274.21
Upgrade
Cash Growth
-31.50%-36.61%-39.10%-62.15%45.16%93.85%-55.86%16.36%12.62%17.08%
Upgrade
Receivables
13.871720.1922.0823.4381.452.2431.4732.2130.78
Upgrade
Inventory
12.7518.5528.6825.2229.0137.543.1436.4826.8426.17
Upgrade
Other Current Assets
10.821.3869.57-15.1429.3215.3218.6724.0422.8536.17
Upgrade
Total Current Assets
82.12102.16221.34201.11528.11441.7272.66451.32390.72367.33
Upgrade
Property, Plant & Equipment
7.8911.1325.74165.9860.5236.6734.3140.246.0916.53
Upgrade
Long-Term Investments
00000000093.3
Upgrade
Goodwill and Intangibles
305.09335.98366.98402.33710.63717.211,023614.49615.7717.46
Upgrade
Other Long-Term Assets
0.56.218.6230.30.412.3912.535.2812.48112.51
Upgrade
Total Long-Term Assets
313.48353.31411.35598.61771.56756.271,070659.98674.35239.79
Upgrade
Total Assets
395.6455.47632.68799.721,3001,1981,3421,1111,065607.13
Upgrade
Accounts Payable
9.8110.8512.1626.2648.8627.3726.9314.2317.7515.92
Upgrade
Deferred Revenue
0.38000032.4641.5150.5789.05100.78
Upgrade
Current Debt
1.558.1976.588.350.620.657.021.171.141.14
Upgrade
Other Current Liabilities
26.2134.9948.5251.7890.7883.4972.4324.626.44-21.2
Upgrade
Total Current Liabilities
37.9554.03137.2586.39140.26143.96147.990.59114.3896.64
Upgrade
Long-Term Debt
171.37182.76183.37241.27343.14334.48324.03291.53289.883.23
Upgrade
Other Long-Term Liabilities
92.6567.5574.1161.25204.29199.55206.19126.15120.5466.9
Upgrade
Total Long-Term Liabilities
264.02250.31257.47402.51547.43534.02530.22417.68410.4370.13
Upgrade
Total Liabilities
301.97304.33394.73488.9687.68677.98678.12508.27524.81166.77
Upgrade
Total Debt
172.92190.94259.95249.61343.76335.12331.05292.7291.034.37
Upgrade
Debt Growth
-9.44%-26.55%4.14%-27.39%2.58%1.23%13.10%0.57%6556.61%-18.86%
Upgrade
Retained Earnings
-936.27-870.36-766.4-666.81-393.84-455.11-243.97-209.35-220.41-238.08
Upgrade
Comprehensive Income
0.63-1.02-2.8-1.172.816.86-12.9-0.12-0.070.04
Upgrade
Shareholders' Equity
93.62151.14237.96310.82611.98519.99664.21603.03540.26440.35
Upgrade
Net Cash / Debt
-128.24-125.72-157.05-80.67102.58-27.64-172.4466.6417.8269.83
Upgrade
Net Cash / Debt Growth
-------274.47%-93.40%17.93%
Upgrade
Net Cash Per Share
-130.15-236.74-388.56-203.53260.03-72.11-457.19183.3350.20776.83
Upgrade
Working Capital
44.1748.1384.08114.73387.85297.74124.76360.73276.34270.69
Upgrade
Book Value Per Share
95.01284.60588.71784.211562.171356.511761.091713.541575.471314.22
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).